New Leroy Hood-led Dx firm gains $30m
This article was originally published in Clinica
A newly launched Seattle, Washington firm, which will specialise in genomic and proteomic technologies for personalised and preventative diagnostics, has raised $30m in its first round of financing. Investors in Integrated Diagnostics include InterWest Partners, which led the round; The Wellcome Trust and dievini Hopp BioTech. The founder of Integrated Diagnostics is Leroy Hood, inventor of the DNA sequencer and current president of The Institute of Biology. The company will have access to Dr Hood's research on protein blood markers which can give an indication on the physiological state of the body's 50 major organs. By monitoring concentrations of these proteins in the blood, disruptions in healthy function can be detected and traced back to the diseased organ, according to Integrated Diagnostics.
You may also be interested in...
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.